Scripps (SSP) issues one right per share at $2.19 exercise price
Rhea-AI Filing Summary
The E.W. Scripps Company (SSP) has adopted a shareholder rights plan. On November 25, 2025, its board declared a dividend of one right for each outstanding Class A Common Share and Common Voting Share, payable to holders of record on December 8, 2025. Each right will, once exercisable, allow the holder to buy one corresponding share at an exercise price of $2.19, subject to adjustment.
The rights become exercisable if any person or group acquires 10% or more of the outstanding Class A Common Shares or starts a tender or exchange offer that would reach that level. If triggered, the plan includes “flip-in” and “flip-over” features that let other holders buy shares at terms designed to substantially dilute the acquiring person’s position. The rights expire on the earliest of November 26, 2026, redemption or exchange by the board, or the 2026 annual meeting if stockholders do not approve the plan.
Positive
- None.
Negative
- None.
Insights
Scripps adopts a one-year rights plan with a 10% trigger.
The E.W. Scripps Company has implemented a shareholder rights plan by issuing one right for each Class A Common Share and Common Voting Share. Each right allows purchase of one share at an exercise price of $2.19, once the plan is triggered. The rights are issued as a dividend to holders of record on December 8, 2025.
The plan is designed to activate if a person or group acquires beneficial ownership of at least 10% of the Class A Common Shares or launches a tender or exchange offer to reach that level. If this happens, the “flip-in” feature lets other holders buy shares with a fair market value of about two times the exercise price, and a “flip-over” feature applies if Scripps is later involved in a merger or major asset sale.
The rights are redeemable by the board at $0.001 per right before anyone becomes an acquiring person and can also be exchanged for shares after a trigger but before an acquirer reaches 50% ownership. The rights expire on the earliest of November 26, 2026, redemption or exchange, or the 2026 annual meeting if stockholders do not approve the plan, so future disclosures around that meeting will clarify whether the plan remains in place.